Polymorphic size of Lipoprotein (a) and structural bioprosthetic valve degeneration

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Romain Capoulade

Institut du Thorax, Nantes (France)

4 More presentations in this session

Presentation thumbnail

new insights into the pathophysiology of rheumatic valve disease based on different genetic and proteomics profiles.

Doctor A. Almeida Valadares (Sao Paulo, BR)

Abstract Slides Video

Presentation thumbnail

Subendocardial ischemic-like state in patients with severe aortic stenosis: insights from myocardial histopathology and ultrastructure.

Doctor R. Reis Santos (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Causal association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis

Doctor W. Nie (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

The effect of the LPA gene on aortic valve calcification in a Portuguese population

Doctor F. Sousa (Funchal, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Unravelling the pathophysiology of valvular heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

The effect of the LPA gene on aortic valve calcification in a Portuguese population

Congress Presentation

Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease

Congress Presentation

Lipoprotein(a) levels and LPA genotypes are not associated with echocardiographic measures of left ventricular structure and function in the general population

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources